Breaking News, Promotions & Moves

Alkermes Announces CEO Succession Details

Richard Pops will retire from his CEO role, but continue to serve as Chairman of the Board.

Author Image

By: Patrick Lavery

Content Marketing Editor

Alkermes, a global biopharmaceutical company headquartered in Ireland, is transitioning to a new Chief Executive Officer (CEO). Richard Pops is retiring from that role effective July 31, 2026. Beginning August 1, Blair Jackson becomes the company’s new CEO, and will also join Alkermes’ Board of Directors. Jackson, who has been with Alkermes since 1999, currently serves as the company’s Executive Vice President, Chief Operating Officer. He is also on the Board of Directors of Synchronicity Pha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters